Additionally, when the metabolism of insulin leads to the occurrence of NAFLD, fat accumulation in the liver leads to hepatocyte injury, activating inflammatory responses and releasing cytokines such as TNF-α and IL-6. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.